(Q54505944)

30 May 2018

title

High prevalence of exon 8 G533C mutation in apparently sporadic medullary thyroid carcinoma in Greece. (English)

1 reference

30 May 2018

1 reference

1 reference

H L Sarika

1

1 reference

30 May 2018

A Papathoma

2

1 reference

30 May 2018

M Garofalaki

3

1 reference

30 May 2018

V Vasileiou

4

1 reference

30 May 2018

B Vlassopoulou

5

1 reference

30 May 2018

E Anastasiou

6

1 reference

30 May 2018

M Alevizaki

7

1 reference

30 May 2018

publication date

1 December 2012

1 reference

30 May 2018

published in

Clinical Endocrinology

1 reference

30 May 2018

volume

77

1 reference

30 May 2018

issue

6

1 reference

30 May 2018

page(s)

857-862

1 reference

30 May 2018

RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04462.X

The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04462.X

Medullary thyroid cancer: management guidelines of the American Thyroid Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04462.X

RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04462.X

A Novel Germ-Line Point Mutation in RET Exon 8 (Gly533Cys) in a Large Kindred with Familial Medullary Thyroid Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04462.X

Multiple endocrine neoplasia type 2A in two families with the familial medullary thyroid carcinoma associated G533C mutation of the RET proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04462.X

Analysis of inherited genetic variants in ret proto-oncogene of Brazilian patients with apparently sporadic medullary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04462.X

Ret proto-oncogene mutations in apparently sporadic Turkish medullary thyroid carcinoma patients: Turkmen study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04462.X

Molecular analysis of the RET proto-oncogene key exons in patients with medullary thyroid carcinoma: a comprehensive study of the Iranian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04462.X

Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04462.X

The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04462.X

RET codon 634 mutations in multiple endocrine neoplasia type 2: variable clinical features and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04462.X

RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04462.X

Four novel RET germline variants in exons 8 and 11 display an oncogenic potential in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04462.X

A new germline point mutation in Ret exon 8 (cys515ser) in a family with medullary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04462.X

Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: a multicenter study of the Groupe Francais d'Etude des Tumeurs Endocrines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04462.X

Evaluation of RET polymorphisms in a six-generation family with G533C RET mutation: specific RET variants may modulate age at onset and clinical presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04462.X

A rareRETgene exon 8 mutation is found in two Greek kindreds with familial medullary thyroid carcinoma: implications for screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04462.X

Risk and Penetrance of Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A Families with Mutations at Codon 634 of the RET Proto-Oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04462.X

Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04462.X

10.1111/J.1365-2265.2012.04462.X

21 January 2018

Identifiers

DOI

1 reference

30 May 2018

1 reference

30 May 2018